Sarah Siederer

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Akram Khan, Cody Benthin, Brian Zeno et al. · Critical Care · 2017 · 631 citations · Full text

Medicine, Pharmacokinetics, Pharmacotherapy +15

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

Toby M. Maher, Juliet K. Simpson, Joanna C. Porter et al. · Respiratory Research · 2020 · 81 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD

Rodger Kempsford, Virginia Norris, Sarah Siederer · Pulmonary Pharmacology & Therapeutics · 2012 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +15

Metabolism and Disposition of Vilanterol, a Long-Acting β2-Adrenoceptor Agonist for Inhalation Use in Humans

Andrew W. Harrell, Sarah Siederer, Jo Bal et al. · Drug Metabolism and Disposition · 2012 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Effect of Once-Daily Fluticasone Furoate/Vilanterol on 24-Hour Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease: A Randomized, Three-Way, Incomplete Block, Crossover Study

Joseph Boscia, Krishna Pudi, Michael T. Zvarich et al. · Clinical Therapeutics · 2012 · 48 citations

Medicine, Pharmacology, Pharmacotherapy +17